Pharmacologic Therapy In Traumatic Brain Injury: Update On Experimental Treatment Strategies

Author(s): H. L. Laurer, T. K. McIntosh

Journal Name: Current Pharmaceutical Design

Volume 7 , Issue 15 , 2001

Become EABM
Become Reviewer
Call for Editor


Considerable effort has led to an increased interest in emerging preclinical and clinical data regarding the pathophysiological changes in the posttraumatic brain. It is widely believed that delayed cell damage and death contributes to behavioral impairment following traumatic brain injury. However, no drug therapy to attenuate this process is available at present, and the development of new therapeutic regimen is urgently warranted. This manuscript represents a compendium of recent preclinical work undertaken to evaluate new pharmacologic strategies in the experimental setting as a first step towards the development of a therapeutic armamentarium directed to improve functional recovery in head-injured patients.

Keywords: Pharmacology therapy, Traumatic brain injury, Cation homeostasis, Glutamate antagonists, Calpain antagonists, Cytoskeleton, Nitric oxide, Nitric oxide synthetase, Free rasical scavengers, Lipid peroxidation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [1505 - 1516]
Pages: 12
DOI: 10.2174/1381612013397285
Price: $65

Article Metrics

PDF: 3